First patient enrolled in the AMLM22-CADENCE trial with Mendus’ product vididencel

What we doOur approachPipelineTechnologyPublications
About usExecutive ManagementBoard of DirectorsScientific Advisory Board
News & eventsPress releasesEventsInterviews
Investors
Careers

Back
First patient enrolled in the AMLM22-CADENCE trial with Mendus’ product vididencel
 8:00:00 AM

Keep reading
Mendus to participate in investor and industry conferences in MarchRead